ScinoPharm Taiwan, Ltd. approved, at board meeting, held on July 5, 2018, the appointment of Tsung-Ming Su as the President & CEO of the Company, replaced Yung-Fa Chen as the President & CEO of the Company. Tsung-Ming Su was Vice President of Uni-President Enterprises Corp.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.5 TWD | +1.42% | -2.90% | +7.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.95% | 690M | |
+37.64% | 727B | |
-7.94% | 354B | |
+15.59% | 328B | |
-0.34% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.87% | 164B | |
-2.14% | 164B |
- Stock Market
- Equities
- 1789 Stock
- News ScinoPharm Taiwan, Ltd.
- Scinopharm Taiwan, Ltd. Approves Management Changes